Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour

British Journal of Obstetrics and Gynaecology

Volumn 108, Issue 2, 2001, Pages 133-142

  Moutquin, J M ^a   Cabrol, D ^a   Fisk, N M ^a   MacLennan, A H ^a   Marsal K ^a   Rabinovici, J ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; OXYTOCIN ANTAGONIST; RITODRINE; SALBUTAMOL; TERBUTALINE;

ADULT; ARTICLE; BIRTH WEIGHT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN MORBIDITY; PREMATURE LABOR; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UTERINE CERVIX DILATATION; UTERUS CONTRACTION;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RITODRINE; TERBUTALINE; TOCOLYTIC AGENTS; TREATMENT OUTCOME; VASOTOCIN;

EID: 0035108210     PISSN: 03065456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-5456(00)00043-7     Document Type: Article

References (26)

1. The importance of preterm birth
2. Contribution of preterm delivery to perinatal mortality
3. Neonatal morbidity according to gestational age and birthweight from five tertiary care centers in the United States 1983 through 1986
4. Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994 Northern Neonatal Network
5. The effects of corticosteroid administration prior to preterm delivery: An overview from the evidence from controlled trials
6. Comparative mortality and morbidity of infants transferred in utero or postnatally
7. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care
8. Current perspectives on drug treatment for preterm labour
9. Beta-mimetics in preterm labour: An overview of the randomized controlled trials
10. Treatment of preterm labor with the beta-adrenergic agonist ritodrine
11. Tocolytic therapy
12. Cardiac isoenzymes and electrocardiographic changes during ritodrine tocolysis
13. The contemporary use of β-agonists
14. Oxytocin secretion and human parturition: Pulse frequency and duration increase during spontaneous labor in women
15. Receptors for myometrial responses to oxytocin and vasopressin in preterm human pregnancy: Effects of the oxytocin antagonist atosiban
16. The effect of the oxytocin antagonists F314 and F792 in the in vitro contractility of human myometrium
17. Oxytocin receptors in pregnant human uterus
18. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human
19. Treatment of preterm labor with the oxytocin antagonist atosiban
20. Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects
21. Dose ranging study of the oxytocin antagonist atosiban in the treatment of preterm labor
22. A double-blind placebo-controlled trial of an oxytocin-receptor antagonist (Antocin) in the treatment of preterm labor
23. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the effect of corticosteroids for fetal maturation on perinatal outcomes